IL137150A0 - Method for administering monomeric insulin analogs - Google Patents

Method for administering monomeric insulin analogs

Info

Publication number
IL137150A0
IL137150A0 IL13715099A IL13715099A IL137150A0 IL 137150 A0 IL137150 A0 IL 137150A0 IL 13715099 A IL13715099 A IL 13715099A IL 13715099 A IL13715099 A IL 13715099A IL 137150 A0 IL137150 A0 IL 137150A0
Authority
IL
Israel
Prior art keywords
insulin analogs
monomeric insulin
administering monomeric
administering
analogs
Prior art date
Application number
IL13715099A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL137150A0 publication Critical patent/IL137150A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
IL13715099A 1998-01-08 1999-01-07 Method for administering monomeric insulin analogs IL137150A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7075298P 1998-01-08 1998-01-08
PCT/US1999/000324 WO1999034816A1 (en) 1998-01-08 1999-01-07 Method for administering monomeric insulin analogs

Publications (1)

Publication Number Publication Date
IL137150A0 true IL137150A0 (en) 2001-07-24

Family

ID=22097181

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13710599A IL137105A0 (en) 1998-01-08 1999-01-07 Method for administering aspb28-human insulin
IL13715099A IL137150A0 (en) 1998-01-08 1999-01-07 Method for administering monomeric insulin analogs

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL13710599A IL137105A0 (en) 1998-01-08 1999-01-07 Method for administering aspb28-human insulin

Country Status (16)

Country Link
US (2) US20010053761A1 (zh)
EP (2) EP0951910A3 (zh)
JP (2) JP2002500193A (zh)
KR (2) KR20010033940A (zh)
CN (2) CN1195543C (zh)
AU (2) AU754707B2 (zh)
BR (2) BR9906813A (zh)
CA (2) CA2317733A1 (zh)
EA (2) EA200000747A1 (zh)
HU (2) HUP0100391A3 (zh)
IL (2) IL137105A0 (zh)
NO (2) NO20003050D0 (zh)
PL (2) PL341592A1 (zh)
TR (2) TR200001892T2 (zh)
WO (2) WO1999034816A1 (zh)
ZA (2) ZA99104B (zh)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6131567A (en) * 1993-01-29 2000-10-17 Aradigm Corporation Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
US20060171899A1 (en) * 1998-12-10 2006-08-03 Akwete Adjei Water-stabilized aerosol formulation system and method of making
US6858199B1 (en) * 2000-06-09 2005-02-22 Advanced Inhalation Research, Inc. High efficient delivery of a large therapeutic mass aerosol
EP1196445A1 (en) * 1999-06-29 2002-04-17 Eli Lilly And Company Insulin crystals for pulmonary administration
US6458387B1 (en) * 1999-10-18 2002-10-01 Epic Therapeutics, Inc. Sustained release microspheres
US7374782B2 (en) 2000-10-27 2008-05-20 Baxter International Inc. Production of microspheres
DE60226613D1 (de) * 2001-08-16 2008-06-26 Baxter Int Darreichungsformen welche mikropartikel und treibgas enthalten
EP1944016A1 (en) 2001-08-16 2008-07-16 Baxter International Inc. Propellant-based microparticle formulatons
US7641823B2 (en) * 2001-12-07 2010-01-05 Map Pharmaceuticals, Inc. Synthesis of small particles
EP1572126A4 (en) * 2001-12-21 2006-07-05 Smithkline Beecham Corp COMPOSITIONS AND METHOD FOR CHANGING GLUCOSE PRODUCTION
US6985798B2 (en) * 2002-05-10 2006-01-10 Oriel Therapeutics, Inc. Dry powder dose filling systems and related methods
US7677411B2 (en) 2002-05-10 2010-03-16 Oriel Therapeutics, Inc. Apparatus, systems and related methods for processing, dispensing and/or evaluatingl dry powders
EP1534366B1 (en) * 2002-06-27 2014-01-08 Oriel Therapeutics, Inc. Dry powder dose filling systems and related methods
US20070277820A1 (en) * 2003-10-27 2007-12-06 Timothy Crowder Blister packages and associated methods of fabricating dry powder drug containment systems
US7377277B2 (en) * 2003-10-27 2008-05-27 Oriel Therapeutics, Inc. Blister packages with frames and associated methods of fabricating dry powder drug containment systems
US7451761B2 (en) * 2003-10-27 2008-11-18 Oriel Therapeutics, Inc. Dry powder inhalers, related blister package indexing and opening mechanisms, and associated methods of dispensing dry powder substances
WO2005065756A2 (en) 2003-12-30 2005-07-21 Oriel Therapeutics, Inc. Dry powder nebulizers and associated methods of dispensing dry powders
US7624733B2 (en) 2004-02-09 2009-12-01 Oriel Therapeutics, Inc. Inhalers with extendable/retractable forward member and associated methods of dispensing inhalant substances
US8365725B2 (en) * 2004-09-13 2013-02-05 Oriel Therapeutics, Inc. Dry powder inhalers that inhibit agglomeration, related devices and methods
EP1934805A4 (en) * 2005-08-25 2017-01-11 Oriel Therapeutics, Inc. Drug containment systems with sticks, related kits, dry powder inhalers and methods
CA2635622C (en) * 2006-01-31 2015-03-31 Oriel Therapeutics, Inc. Dry powder inhalers having spiral travel paths, unit dose microcartridges with dry powder, related devices and methods
EP2060268A1 (en) * 2007-11-15 2009-05-20 Novo Nordisk A/S Pharmaceutical compositions for pulmonary or nasal delivery of peptides
JP5470393B2 (ja) 2008-09-26 2014-04-16 オリエル・セラピューティクス，インコーポレイテッド ドライパウダー吸入器
CA2732826C (en) 2008-09-26 2017-08-22 Oriel Therapeutics, Inc. Inhaler mechanisms with radially biased piercers and related methods
KR101311977B1 (ko) * 2008-09-26 2013-09-26 오리엘 테라퓨틱스, 인크. 분리된 공기통로 채널들을 갖는 공기통로 디스크들 및 관련된 디스크들을 구비한 흡입기 및 이와 관련된 방법
US9050427B2 (en) * 2008-09-30 2015-06-09 Oriel Therapeutics, Inc. Dry powder inhalers with multi-facet surface deagglomeration chambers and related devices and methods
WO2010039200A2 (en) * 2008-09-30 2010-04-08 Oriel Therapeutics, Inc. Dry powder inhalers with endless strips and cooperating piercers and related methods
MX2011003245A (es) * 2008-10-01 2011-04-26 Oriel Therapeutics Inc Inhaladores de polvo seco con mecanismos de perforacion giratorios y dispositivos y metodos relacionados.
JP5341532B2 (ja) * 2009-01-19 2013-11-13 第一電子工業株式会社 １対の誤嵌合防止キー及び該キーを用いた電気コネクタ
CN101912600B (zh) * 2010-01-11 2014-01-29 杨国汉 改善胰岛素在溶液中稳定性的方法
WO2011080747A2 (en) 2010-01-27 2011-07-07 Aespira Ltd. Dry powder inhaler
USD635246S1 (en) 2010-03-26 2011-03-29 Oriel Therapeutics, Inc. Dose disk for dry powder inhalers
USD641076S1 (en) 2010-03-26 2011-07-05 Oriel Therapeutics, Inc. Dry powder inhaler
US11491288B2 (en) 2014-01-08 2022-11-08 Seroton, Inc. Dispenser for dry-powder inhalation devices
US10238820B2 (en) 2014-01-08 2019-03-26 Seroton, Inc. Dry-powder inhalation device
WO2024100652A1 (en) 2022-11-07 2024-05-16 Kritzman Kadron Amnon High performance dry powder inhaler

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK179286D0 (da) * 1986-04-18 1986-04-18 Nordisk Gentofte Insulinpraeparat
IL93282A (en) * 1989-02-09 1995-08-31 Lilly Co Eli Insulin analogues
US5230884A (en) * 1990-09-11 1993-07-27 University Of Wales College Of Cardiff Aerosol formulations including proteins and peptides solubilized in reverse micelles and process for making the aerosol formulations
US6131567A (en) * 1993-01-29 2000-10-17 Aradigm Corporation Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
DK72793D0 (da) * 1993-06-21 1993-06-21 Novo Nordisk As Nyt produkt
DE69416409T2 (de) * 1993-06-21 1999-09-16 Novo Nordisk A/S, Bagsvaerd Asp-b28-insulinkristalle
TW402506B (en) * 1993-06-24 2000-08-21 Astra Ab Therapeutic preparation for inhalation
US5451569A (en) * 1994-04-19 1995-09-19 Hong Kong University Of Science And Technology R & D Corporation Limited Pulmonary drug delivery system
US5461031A (en) * 1994-06-16 1995-10-24 Eli Lilly And Company Monomeric insulin analog formulations
US5547929A (en) * 1994-09-12 1996-08-20 Eli Lilly And Company Insulin analog formulations
YU18596A (sh) * 1995-03-31 1998-07-10 Eli Lilly And Company Analogne formulacije monomernog insulina
CA2223272A1 (en) * 1995-05-05 1996-11-07 Ronald Eugene Chance Single chain insulin with high bioactivity

Also Published As

Publication number Publication date
EP0951910A3 (en) 2002-06-19
CN1195543C (zh) 2005-04-06
AU754707B2 (en) 2002-11-21
HUP0101293A2 (hu) 2001-08-28
HUP0100391A3 (en) 2001-12-28
NO20003051L (no) 2000-06-14
TR200001891T2 (tr) 2000-11-21
NO20003050L (no) 2000-06-14
JP2002500193A (ja) 2002-01-08
HUP0101293A3 (en) 2001-12-28
WO1999034816A1 (en) 1999-07-15
JP2002500192A (ja) 2002-01-08
KR20010033940A (ko) 2001-04-25
AU747619B2 (en) 2002-05-16
ZA99105B (en) 2000-07-07
CA2317733A1 (en) 1999-07-15
EP0951910A2 (en) 1999-10-27
BR9906796A (pt) 2000-11-14
CN1287491A (zh) 2001-03-14
HUP0100391A2 (hu) 2001-08-28
US20010053761A1 (en) 2001-12-20
ZA99104B (en) 2000-07-07
EA200000747A1 (ru) 2000-12-25
IL137105A0 (en) 2001-06-14
NO20003051D0 (no) 2000-06-14
EA200000748A1 (ru) 2000-12-25
US20010007853A1 (en) 2001-07-12
PL341592A1 (en) 2001-04-23
CA2317739A1 (en) 1999-07-15
KR20010033941A (ko) 2001-04-25
EP0951911A2 (en) 1999-10-27
WO1999034815A1 (en) 1999-07-15
BR9906813A (pt) 2001-03-20
AU2312299A (en) 1999-07-26
PL342745A1 (en) 2001-07-02
AU2107399A (en) 1999-07-26
TR200001892T2 (tr) 2000-11-21
CN1287492A (zh) 2001-03-14
EP0951911A3 (en) 2002-06-19
NO20003050D0 (no) 2000-06-14

Similar Documents

Publication Publication Date Title
IL137150A0 (en) Method for administering monomeric insulin analogs
ZA989744B (en) Method for administering acylated insulin.
IL141241A0 (en) Method for administering insulinotropic peptides
IL115973A0 (en) Acylated insulin analogs
HUP0100928A3 (en) Methods for treatment of diabetes using peptide analogues of insulin
EP0813428A4 (en) CONE INFUSION PUMP FOR AT LEAST ONE SYRINGE
ZA988030B (en) Fracture healing using pthrp analogs
EP0783334A4 (en) IMPROVED DOUBLE CHAMBER SYRINGE AND METHODS
PL344520A1 (en) Method for purifying aliphatic aminonitriles
HK1119449A1 (en) Process for obtaining insulin or insulin derivatives having correctly bonded cystine bridges
IL116815A0 (en) Carpule for an interligamentary syringe
AU3236895A (en) Aspb1 insulin analogs
IL183972A0 (en) Pharmaceutical composition for modified release insulin sensitiser
HUP0103852A2 (hu) Összeállítás egészségügyi folyadék tárolására és bejuttatására
EP1183032A4 (en) METHOD FOR IMPROVING INSULIN EFFECT
PL345898A1 (en) Novel insulin analogs with enhanced zinc binding
AU4445201A (en) Method for administering insulin to the buccal region
IL139218A0 (en) 2-aroyl-4-acyl-paclitaxel (taxol) analogs
EP0689052A3 (en) Standard insulin solution
IL102240A0 (en) Insulin analogs
GB9712462D0 (en) Dental syringe assemblies
AU136934S (en) Infusion apparatus
GB9816285D0 (en) Hypodermic syringe
ZA90838B (en) Insulin analogs
SI1058660T1 (sl) Postopek doziranja medicinskega pripravka